Unknown NA INTERVENTIONAL 2-arm NCT01138956

Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine (VLNAC)

Study for Evaluation of the Immune Response of Visceral Leishmaniasis Patients Treated With Antimonial Pentavalent Associated to N-Acetylcysteine

Sponsor: Hospital Universitário Professor Edgard Santos

Conditions Immune Response Treatment Visceral Leishmaniasis

Interventions N-acetylcysteine Pentavalent antimonial

Updated 4 times since 2017 Last updated: Jun 7, 2010 Started: Apr 30, 2010 Primary completion: Jun 30, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Immune Response and Treatment and is currently ongoing. Hospital Universitário Professor Edgard Santos leads this study, which shows 4 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jan 2017 — Jan 2021 [monthly]

Unknown Status NA

First recorded

Apr 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitário Professor Edgard Santos

Data source: Hospital Universitário Professor Edgard Santos

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aracaju, Brazil